Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 215

1.

The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent.

Kennedy AR.

Am J Clin Nutr. 1998 Dec;68(6 Suppl):1406S-1412S. Review.

PMID:
9848508
2.

Prevention of carcinogenesis by protease inhibitors.

Kennedy AR.

Cancer Res. 1994 Apr 1;54(7 Suppl):1999s-2005s. Review.

3.

Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia.

Armstrong WB, Kennedy AR, Wan XS, Atiba J, McLaren CE, Meyskens FL Jr.

Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):43-7.

4.

Effects of Bowman-Birk inhibitor on rat colon carcinogenesis.

Kennedy AR, Billings PC, Wan XS, Newberne PM.

Nutr Cancer. 2002;43(2):174-86.

PMID:
12588698
5.
6.

Chemopreventive agents: protease inhibitors.

Kennedy AR.

Pharmacol Ther. 1998 Jun;78(3):167-209. Review.

PMID:
9690817
7.

Preparation and production of a cancer chemopreventive agent, Bowman-Birk inhibitor concentrate.

Kennedy AR, Szuhaj BF, Newberne PM, Billings PC.

Nutr Cancer. 1993;19(3):281-302.

PMID:
8346077
8.

Cancer prevention by protease inhibitors.

Kennedy AR.

Prev Med. 1993 Sep;22(5):796-811. Review.

PMID:
8234219
10.

The protease inhibitor, Bowman-Birk Inhibitor, suppresses experimental autoimmune encephalomyelitis: a potential oral therapy for multiple sclerosis.

Gran B, Tabibzadeh N, Martin A, Ventura ES, Ware JH, Zhang GX, Parr JL, Kennedy AR, Rostami AM.

Mult Scler. 2006 Dec;12(6):688-97.

PMID:
17262995
12.

Development of Bowman-Birk inhibitor for chemoprevention of oral head and neck cancer.

Meyskens FL.

Ann N Y Acad Sci. 2001 Dec;952:116-23. Review.

PMID:
11795430
13.

Internalisation of the Bowman-Birk protease inhibitor by intestinal epithelial cells.

Billings PC, Brandon DL, Habres JM.

Eur J Cancer. 1991;27(7):903-8. Erratum in: Eur J Cancer 1991;27(9):1190.

PMID:
1834126
14.

Effects of various preparations of dietary protease inhibitors on oral carcinogenesis in hamsters induced by DMBA.

Kennedy AR, Billings PC, Maki PA, Newberne P.

Nutr Cancer. 1993;19(2):191-200.

PMID:
8502589
15.

Effect of the Bowman-Birk inhibitor (a soy protein) on in vitro bladder neck/urethral and penile corporal smooth muscle activity.

Malkowicz SB, Liu SP, Broderick GA, Wein AJ, Kennedy AR, Levin RM.

Neurourol Urodyn. 2003;22(1):54-7.

PMID:
12478602
16.
17.
18.

Suppression of dimethylhydrazine-induced carcinogenesis in mice by dietary addition of the Bowman-Birk protease inhibitor.

St Clair WH, Billings PC, Carew JA, Keller-McGandy C, Newberne P, Kennedy AR.

Cancer Res. 1990 Feb 1;50(3):580-6.

19.

Urinary excretion of Bowman-Birk inhibitor in humans after soy consumption as determined by a monoclonal antibody-based immunoassay.

Wan XS, Lu LJ, Anderson KE, Ware JH, Kennedy AR.

Cancer Epidemiol Biomarkers Prev. 2000 Jul;9(7):741-7.

20.

Suppression of carcinogenesis in the intestines of min mice by the soybean-derived Bowman-Birk inhibitor.

Kennedy AR, Beazer-Barclay Y, Kinzler KW, Newberne PM.

Cancer Res. 1996 Feb 15;56(4):679-82.

Items per page

Supplemental Content

Write to the Help Desk